IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
16 hedge funds and large institutions have $684K invested in ImmunoCellular Therapeutics, Ltd. in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$83.3K | |
| 2 | +$17.5K | |
| 3 | +$994 | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$144 |
Top Sellers
| 1 | -$25K | |
| 2 | -$10K | |
| 3 | -$10K | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$9K |
| 5 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
-$7K |